company background image
VTRS logo

Viatris NasdaqGS:VTRS Stock Report

Last Price


Market Cap







28 Feb, 2024


Company Financials +

Viatris Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Viatris
Historical stock prices
Current Share PriceUS$13.23
52 Week HighUS$13.62
52 Week LowUS$8.74
1 Month Change11.36%
3 Month Change44.12%
1 Year Change16.98%
3 Year Change-4.68%
5 Year Change-51.11%
Change since IPO2,057.65%

Recent News & Updates

From Euphoria To Reality: Viatris' Tale Of Market Whirlwind

Jan 12

Recent updates

From Euphoria To Reality: Viatris' Tale Of Market Whirlwind

Jan 12

Viatris stock rises amid potential plans for €3B sale of European OTC assets

Oct 11

Take These Broken Wings And Learn To Fly Again Viatris

Sep 25

Viatris: 5% Dividend Yield Is A Threat For Investors

Sep 06

Viatris: Products, Profitability And Pipeline - The Keys To Success

Aug 20

Viatris declares $0.12 dividend

Aug 08

Viatris: A Spinoff To Own

Aug 02

Viatris extends decline to reach 52-week low

Jul 22

Viatris: Guidance Likely To Be Cut With Q2 Results

Jul 15

Viatris: The Market Is Not Buying It - Downtrend Since 2015

May 09

Viatris: 3 Things That Can Break The Bull Thesis In 2022

Apr 20

I No Longer Think Viatris Is A Buy

Apr 08

Viatris: Takeaways From Management At The Raymond James Conference

Mar 10

My Investment Thesis On Viatris Remains Intact After The Sale Of The Biosimilars Assets

Feb 28

Viatris: Cheap Stock, Solid Dividend Yield, And Impressive Free Cash Flow

Jan 20

Viatris: Prepare For Takeoff

Jan 11

Viatris Is A Strong Buy

Dec 10

Viatris: A Look At Whether Q3 Sales Can Tilt The Scales

Nov 08

Shareholder Returns

VTRSUS PharmaceuticalsUS Market

Return vs Industry: VTRS underperformed the US Pharmaceuticals industry which returned 26.1% over the past year.

Return vs Market: VTRS underperformed the US Market which returned 26% over the past year.

Price Volatility

Is VTRS's price volatile compared to industry and market?
VTRS volatility
VTRS Average Weekly Movement4.0%
Pharmaceuticals Industry Average Movement10.0%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: VTRS's share price has been volatile over the past 3 months.

Volatility Over Time: VTRS's weekly volatility (4%) has been stable over the past year.

About the Company

196138,000Scott Smith

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).

Viatris Inc. Fundamentals Summary

How do Viatris's earnings and revenue compare to its market cap?
VTRS fundamental statistics
Market capUS$16.11b
Earnings (TTM)US$1.83b
Revenue (TTM)US$15.47b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VTRS income statement (TTM)
Cost of RevenueUS$8.83b
Gross ProfitUS$6.64b
Other ExpensesUS$4.81b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Feb 28, 2024

Earnings per share (EPS)1.53
Gross Margin42.93%
Net Profit Margin11.84%
Debt/Equity Ratio88.1%

How did VTRS perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.